Research Article
Circulating Levels of CILP2 Are Elevated in Coronary Heart Disease and Associated with Atherosclerosis
Figure 4
CILP2 modulates the CD36 expressions via the PPARγ signaling pathway. THP-1 macrophages were treated as in the Methods. (a) CD36, LOX-1, and SR-A mRNA expression. (b) ABCA1 and ABCG1 mRNA expression. (c) CD36 protein levels. (d) Quantitative analysis of CD36 protein levels. (e) PPARγ mRNA expression. (f, g) Effects of GW9662 and rosiglitazone treatment on CD36 (f) and LOX-1 (g) mRNA expression. (h) CILP2-mediated transcriptional activation in the full-length CD36 promoter. Data are expressed as . and vs. GFP-oxLDL or GFP or lane 1.
(a) |
(b) |
(c) |
(d) |
(e) |
(f) |
(g) |
(h) |